JP2020516672A5 - - Google Patents

Download PDF

Info

Publication number
JP2020516672A5
JP2020516672A5 JP2019556274A JP2019556274A JP2020516672A5 JP 2020516672 A5 JP2020516672 A5 JP 2020516672A5 JP 2019556274 A JP2019556274 A JP 2019556274A JP 2019556274 A JP2019556274 A JP 2019556274A JP 2020516672 A5 JP2020516672 A5 JP 2020516672A5
Authority
JP
Japan
Prior art keywords
pyrazole
methyl
oxo
benzonitrile
dihydropyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019556274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020516672A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/028097 external-priority patent/WO2018195155A1/en
Publication of JP2020516672A publication Critical patent/JP2020516672A/ja
Publication of JP2020516672A5 publication Critical patent/JP2020516672A5/ja
Priority to JP2023009579A priority Critical patent/JP2023088901A/ja
Pending legal-status Critical Current

Links

JP2019556274A 2017-04-18 2018-04-18 治療用化合物 Pending JP2020516672A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023009579A JP2023088901A (ja) 2017-04-18 2023-01-25 治療用化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762486894P 2017-04-18 2017-04-18
US62/486,894 2017-04-18
US201862657456P 2018-04-13 2018-04-13
US62/657,456 2018-04-13
PCT/US2018/028097 WO2018195155A1 (en) 2017-04-18 2018-04-18 Therapeutic compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023009579A Division JP2023088901A (ja) 2017-04-18 2023-01-25 治療用化合物

Publications (2)

Publication Number Publication Date
JP2020516672A JP2020516672A (ja) 2020-06-11
JP2020516672A5 true JP2020516672A5 (enExample) 2021-04-30

Family

ID=63791349

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019556274A Pending JP2020516672A (ja) 2017-04-18 2018-04-18 治療用化合物
JP2023009579A Pending JP2023088901A (ja) 2017-04-18 2023-01-25 治療用化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023009579A Pending JP2023088901A (ja) 2017-04-18 2023-01-25 治療用化合物

Country Status (5)

Country Link
US (4) US10617680B2 (enExample)
EP (1) EP3612522A4 (enExample)
JP (2) JP2020516672A (enExample)
TW (2) TWI788343B (enExample)
WO (1) WO2018195155A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI788343B (zh) * 2017-04-18 2023-01-01 美商塞爾基因定量細胞研究公司 治療用化合物
MX2023013508A (es) * 2018-06-29 2023-12-13 Forma Therapeutics Inc Inhibicion de la proteina de union a creb (cbp).
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
TW202304303A (zh) 2021-04-13 2023-02-01 美商富曼西公司 殺真菌之吡啶酮
US20240308998A1 (en) 2021-06-29 2024-09-19 Tay Therapeutics Limited Pyrrolopyridone derivatives useful in the treatment of cancer
WO2025010291A2 (en) * 2023-07-03 2025-01-09 The General Hospital Corporation Targeted epigenetic therapies for disorders of progranulin deficiency

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406329A1 (de) 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
EP0825989A1 (en) 1995-05-19 1998-03-04 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
WO1997001551A1 (en) * 1995-06-26 1997-01-16 Fujisawa Pharmaceutical Co., Ltd. Pyrazole compounds and pharmaceutical compositions
JP3760957B2 (ja) 1996-03-05 2006-03-29 信越化学工業株式会社 新規スルホニウム塩及び化学増幅ポジ型レジスト材料
CA2376835C (en) * 1999-07-02 2009-09-15 Eisai Co., Ltd. Condensed imidazole compounds and a therapeutic agent for diabetes mellitus
AU2002306868A1 (en) * 2001-03-28 2002-10-15 Pharmacia Corporation Therapeutic combinations for cardiovascular and inflammatory indications
KR20060097105A (ko) * 2003-07-22 2006-09-13 얀센 파마슈티카 엔.브이. C-fms 키나아제 저해제로서의 퀴놀리논 유도체
US7226920B2 (en) * 2003-08-06 2007-06-05 Vertex Pharmaceuticals Inc. Aminotriazole compounds useful as inhibitors of protein kinases
JP4978192B2 (ja) * 2004-04-01 2012-07-18 アステラス製薬株式会社 ピラジン誘導体およびその医薬的使用
EP1604988A1 (en) * 2004-05-18 2005-12-14 Sanofi-Aventis Deutschland GmbH Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
US7361654B2 (en) 2005-01-13 2008-04-22 Bristol-Myers Squibb Co. Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
JPWO2006137465A1 (ja) * 2005-06-24 2009-01-22 塩野義製薬株式会社 含窒素複素環誘導体
TW200745034A (en) 2005-09-01 2007-12-16 Astellas Pharma Inc New compounds
RU2008112691A (ru) * 2005-10-03 2009-10-10 Оно Фармасьютикал Ко., Лтд. (Jp) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
KR101352973B1 (ko) 2005-10-26 2014-01-22 삼성에스디아이 주식회사 연료전지용 탈황흡착제 및 이를 이용한 탈황방법
CA2646023A1 (en) * 2006-03-10 2007-09-20 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
CN101426774B (zh) * 2006-04-19 2012-04-25 安斯泰来制药有限公司 唑类甲酰胺衍生物
WO2007139150A1 (ja) * 2006-05-30 2007-12-06 The University Of Tokushima TNFα阻害物質を含有してなる抗インフルエンザウイルス剤
WO2008039882A1 (en) 2006-09-30 2008-04-03 Sanofi-Aventis U.S. Llc A combination of niacin and a prostaglandin d2 receptor antagonist
TW200906825A (en) 2007-05-30 2009-02-16 Scripps Research Inst Inhibitors of protein kinases
US20090054434A1 (en) * 2007-08-23 2009-02-26 Amgen Inc. Isoquinolone derivatives as phosphodiesterase 10 inhibitors
CA2697663A1 (en) * 2007-08-30 2009-03-05 Takeda Pharmaceutical Company Limited Substituted pyrazole derivative
CN102131801B (zh) * 2008-06-25 2015-04-08 福拉姆医药股份有限公司 1,2-二取代的杂环化合物
WO2010085805A1 (en) 2009-01-26 2010-07-29 Intermune, Inc. Methods for treating acute myocardial infarctions and associated disorders
GB0919380D0 (en) * 2009-11-04 2009-12-23 Almac Discovery Ltd Pharmaceutical compouds
JP5734313B2 (ja) 2010-01-12 2015-06-17 アーべー・シオンス チアゾールおよびオキサゾールキナーゼ阻害剤
WO2012020786A1 (ja) 2010-08-11 2012-02-16 日本新薬株式会社 医薬組成物
US9481670B2 (en) 2011-01-25 2016-11-01 Sphaera Pharma Pte. Ltd. Triazine compounds
JP2014122161A (ja) * 2011-03-31 2014-07-03 Astellas Pharma Inc ピラゾール化合物
US8809372B2 (en) * 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
JP6176244B2 (ja) 2012-05-30 2017-08-09 日本新薬株式会社 芳香族複素環誘導体及び医薬
EP2858982A4 (en) * 2012-06-12 2015-11-11 Abbvie Inc PYRIDINONE AND PYRIDAZINONE DERIVATIVES
AR092742A1 (es) * 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
MX2015007921A (es) 2012-12-21 2016-03-03 Zenith Epigenetics Corp Compuestos heterociclicos novedosos como inhibidores de bromodominio.
HK1218909A1 (zh) 2013-03-12 2017-03-17 Abbvie Inc. 二氢-吡咯并吡啶酮布罗莫结构域抑制剂
WO2014140077A1 (en) 2013-03-14 2014-09-18 Glaxosmithkline Intellectual Property (No.2) Limited Furopyridines as bromodomain inhibitors
WO2014157569A1 (ja) * 2013-03-28 2014-10-02 武田薬品工業株式会社 複素環化合物
CA2907912A1 (en) 2013-05-01 2014-11-06 F. Hoffmann-La Roche Ag C-linked heterocycloalkyl substituted pyrimidines and their uses
EA035727B1 (ru) * 2013-10-18 2020-07-31 Селджен Квонтисел Рисёрч, Инк. Ингибиторы бромодомена
LT3092227T (lt) 2014-01-09 2018-08-10 Orion Corporation Bicikliniai heterocikliniai dariniai kaip bromodomeno inhibitoriai
RU2692485C2 (ru) * 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
AU2015268962A1 (en) 2014-06-04 2017-01-12 Thomas Helledays Stiftelse For Medicinsk Forskning MTH1 inhibitors for treatment of inflammatory and autoimmune conditions
RU2017112739A (ru) * 2014-09-17 2018-10-17 Версеон Корпорейшн Пиразолил-замещенные пиридоновые соединения как ингибиторы сериновых протеаз
WO2016047678A1 (ja) * 2014-09-25 2016-03-31 武田薬品工業株式会社 複素環化合物
GB201504689D0 (en) * 2015-03-19 2015-05-06 Glaxosmithkline Ip Dev Ltd Chemical compounds
AR104259A1 (es) * 2015-04-15 2017-07-05 Celgene Quanticel Res Inc Inhibidores de bromodominio
AU2016293446A1 (en) * 2015-07-15 2018-02-15 Aurigene Discovery Technologies Limited Substituted aza compounds as IRAK-4 inhibitors
EP3322698A4 (en) 2015-07-15 2019-01-09 Aurigene Discovery Technologies Limited INDAZOL AND AZAINDAZONE COMPOUNDS AS IRAQ-4 INHIBITORS
JP6761805B2 (ja) * 2015-08-12 2020-09-30 持田製薬株式会社 イソチアゾール誘導体
CA3129180A1 (en) * 2015-09-21 2017-03-30 Plexxikon Inc. Heterocyclic compounds and uses thereof
EP3445750A4 (en) 2016-04-18 2019-11-27 Celgene Quanticel Research, Inc. THERAPEUTIC COMPOUNDS
WO2018014802A1 (en) 2016-07-18 2018-01-25 National Institute Of Biological Sciences, Beijing Apoptosis inhibitors
TWI788343B (zh) 2017-04-18 2023-01-01 美商塞爾基因定量細胞研究公司 治療用化合物
AR111479A1 (es) 2017-04-18 2019-07-17 Celgene Quanticel Res Inc Compuestos derivados de piridina y pirazol

Similar Documents

Publication Publication Date Title
JP2020516672A5 (enExample)
RU2481333C2 (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
JP2016512259A5 (enExample)
RU2012146246A (ru) Антибактериальные производные изохинолин-3-илмочевины
ME02437B (me) Disupstituirani oktahidropirolo[3,4-c]piroli kao modulatori oreksin receptora
JP2014531465A5 (enExample)
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
JP2014528446A5 (enExample)
RU2008141509A (ru) Mglur5 модуляторы 1
JP2019530667A5 (enExample)
HRP20210431T1 (hr) Pripravci tetrahidrokinolina kao inhibitori bet bromodomene
HRP20220096T1 (hr) Inhibitori lizin specifične demetilaze-1
RU2017134901A (ru) Соединения 1-циано-пирролидинов в качестве ингибиторов USP30
HRP20201746T1 (hr) Aromatski derivati sulfonamida
JP2007508346A5 (enExample)
JP2007514690A5 (enExample)
HRP20211678T1 (hr) N-supstituirani derivati indola kao modulatori receptora pge2
JP2007510689A5 (enExample)
JP2008521900A5 (enExample)
JP2020522490A5 (enExample)
JP2018516254A5 (enExample)
RU2015137615A (ru) Замещенные пиридиновые и пиразиновые соединения в качестве ингибиторов pde4
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
JP2010513304A5 (enExample)
RU2014149684A (ru) Производные аминохиназолина и пиридопиримидина